Unlike traditional devices, GP1 uses a new sleeve® to the thigh that avoids pain during the treatment
Mixed leg ulcers.
Unbearable pains
Patented sleeve that avoids pain
during the treatment
From the very first sessions,
GP1 improves the healing process
In severe PAD cases, SFC devices (Sequential Foot Calf) increase the foot oxygenation but at the same time, causing severe pain due to the compression on the foot and calf damaged tissues (ulcers and infections).
The sleeve is applied on the thigh where there are no damaged tissues
With more patients compliance to complete the treatments cycle
The compressive effect on the femoral vein is more effective than the one on foot-calf
Oxygen delivery in the foot tissues
The better performance of GP1 is clear
VAS pain scale
Clinical pictures and data published in Veins and Lymphatics 2016; volume 5:5266
Before GP1
After GP1
Before GP1
After GP1
Before GP1
After GP1
The amazing GP1 results are possible thanks to a long randomized control trial completed at the Vascular Disease Center, University of Ferrara, Italy. The trial is already published on important medical journals.
